Recall D-0815-2026

US Class II Ongoing · initiated 2026-08-06

Recalling firm

Baxter Healthcare Corporation, IL

Product

Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50.

Reason for recall

CGMP Deviations

← All recalls